Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity

November 2021 | 181 pages | ID: G719ECBD392BEN
GMD Research

Abstracts

Global drug discovery market will reach $117.6 billion by 2030, growing by 8.6% annually over 2020-2030 driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.

Highlighted with 86 tables and 97 figures, this 181-page report “Global Drug Discovery Market 2020-2030 by Drug Type (Small Molecule, Biologics), Service (Medicinal, Biological, DMPK), Process, Technology, Therapeutic Area, End User, and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global drug discovery market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Region.

Based on Drug Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Small Molecule Drugs
• Biologic Drugs

Based on Service, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Medicinal Chemical Services
• Biological Services
• Drug Metabolism and Pharmacokinetics (DMPK) Services
• Other Pharmaceutical Services

Based on Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Target Selection
• Target Validation
• Hit-To-Lead Identification
• Lead Optimization
• Candidate Validation

Based on Technology, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• High Throughput Screening
• Combinatorial Chemistry
• Pharmacogenomics and Pharmacogenetics
• Nanotechnology
• Bioanalytical Instruments
• Biochips
• Bioinformatics
• Other Technologies

Based on Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Oncology
• Neurology
• Infectious and Immune System Diseases
• Digestive System Diseases
• Cardiovascular Diseases
• Diabetes
• Respiratory Disease
• Other Therapeutic Areas

Based on End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2019-2030 included in each section.

• Pharmaceutical Companies
• Contract Research Organizations (CROs)
• Research Institutes
• Other End Users

Geographically, the following regions together with the listed national/local markets are fully investigated:

• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa)

For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2019-2030. The breakdown of all regional markets by country and split of key national markets by Drug Type, Service, and Therapeutic Area over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Key Players (this may not be a complete list and extra companies can be added upon request):

Abbott Laboratories Inc.

Agilent Technologies Inc.

Astrazeneca plc

Bayer AG

Charles River Laboratories International Inc.

Eli Lilly and Company

F. Hoffmann-La Roche Ltd

GlaxoSmithKline PLC

Merck & Co. Inc.

Novartis AG

Pfizer Inc.

Shimadzu Corp

Thermo Fisher Scientific Inc.

(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF GLOBAL MARKET BY DRUG TYPE

3.1 Market Overview by Drug Type
3.2 Small Molecule Drugs
3.3 Biologic Drugs

4 SEGMENTATION OF GLOBAL MARKET BY SERVICE

4.1 Market Overview by Service
4.2 Medicinal Chemical Services
4.3 Biological Services
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services
4.5 Other Pharmaceutical Services

5 SEGMENTATION OF GLOBAL MARKET BY PROCESS

5.1 Market Overview by Process
5.2 Target Selection
5.3 Target Validation
5.4 Hit-To-Lead Identification
5.5 Lead Optimization
5.6 Candidate Validation

6 SEGMENTATION OF GLOBAL MARKET BY TECHNOLOGY

6.1 Market Overview by Technology
6.2 High Throughput Screening
6.3 Combinatorial Chemistry
6.4 Pharmacogenomics and Pharmacogenetics
6.5 Nanotechnology
6.6 Bioanalytical Instruments
6.7 Biochips
6.8 Bioinformatics
6.9 Other Technologies

7 SEGMENTATION OF GLOBAL MARKET BY THERAPEUTIC AREA

7.1 Market Overview by Therapeutic Area
7.2 Oncology
7.3 Neurology
7.4 Infectious and Immune System Diseases
7.5 Digestive System Diseases
7.6 Cardiovascular Diseases
7.7 Diabetes
7.8 Respiratory Disease
7.9 Other Therapeutic Areas

8 SEGMENTATION OF GLOBAL MARKET BY END USER

8.1 Market Overview by End User
8.2 Pharmaceutical Companies
8.3 Contract Research Organizations (CROs)
8.4 Research Institutes
8.5 Other End Users

9 SEGMENTATION OF GLOBAL MARKET BY REGION

9.1 Geographic Market Overview 2019-2030
9.2 North America Market 2019-2030 by Country
  9.2.1 Overview of North America Market
  9.2.2 U.S.
  9.2.3 Canada
  9.2.4 Mexico
9.3 European Market 2019-2030 by Country
  9.3.1 Overview of European Market
  9.3.2 Germany
  9.3.3 U.K.
  9.3.4 France
  9.3.5 Spain
  9.3.6 Italy
  9.3.7 Russia
  9.3.8 Rest of European Market
9.4 Asia-Pacific Market 2019-2030 by Country
  9.4.1 Overview of Asia-Pacific Market
  9.4.2 Japan
  9.4.3 China
  9.4.4 Australia
  9.4.5 India
  9.4.6 South Korea
  9.4.7 Rest of APAC Region
9.5 South America Market 2019-2030 by Country
  9.5.1 Argentina
  9.5.2 Brazil
  9.5.3 Chile
  9.5.4 Rest of South America Market
9.6 MEA Market 2019-2030 by Country
  9.6.1 UAE
  9.6.2 Saudi Arabia
  9.6.3 South Africa
  9.6.4 Other National Markets

10 COMPETITIVE LANDSCAPE

10.1 Overview of Key Vendors
10.2 New Product Launch, Partnership, Investment, and M&A
10.3 Company Profiles
Abbott Laboratories Inc.
Agilent Technologies Inc.
Astrazeneca plc
Bayer AG
Charles River Laboratories International Inc.
Eli Lilly and Company
F. Hoffmann-La Roche Ltd
GlaxoSmithKline PLC
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Shimadzu Corp
Thermo Fisher Scientific Inc.
RELATED REPORTS

List Of Tables

LIST OF TABLES:

Table 1. Snapshot of Global Drug Discovery Market in Balanced Perspective, 2019-2030
Table 2. Growth Rate of World GDP, 2020-2022
Table 3. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Total Number of Registered Clinical Studies Worldwide, 2010-2019
Table 6. Main Product Trends and Market Opportunities in Global Drug Discovery Market
Table 7. Global Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 8. Global Drug Discovery Market by Service, 2019-2030, $ mn
Table 9. Global Drug Discovery Market by Process, 2019-2030, $ mn
Table 10. Global Drug Discovery Market by Technology, 2019-2030, $ mn
Table 11. Global Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 12. Global Drug Discovery Market by End User, 2019-2030, $ mn
Table 13. Global Drug Discovery Market by Region, 2019-2030, $ mn
Table 14. Leading National Drug Discovery Market, 2019 and 2030F, $ mn
Table 15. North America Drug Discovery Market by Country, 2019-2030, $ mn
Table 16. U.S. Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 17. U.S. Drug Discovery Market by Service, 2019-2030, $ mn
Table 18. U.S. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 19. Novel Drug Approvals in U.S. in 2020
Table 20. Canada Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 21. Canada Drug Discovery Market by Service, 2019-2030, $ mn
Table 22. Canada Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 23. Mexico Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 24. Mexico Drug Discovery Market by Service, 2019-2030, $ mn
Table 25. Mexico Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 26. Europe Drug Discovery Market by Country, 2019-2030, $ mn
Table 27. Germany Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 28. Germany Drug Discovery Market by Service, 2019-2030, $ mn
Table 29. Germany Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 30. U.K. Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 31. U.K. Drug Discovery Market by Service, 2019-2030, $ mn
Table 32. U.K. Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 33. France Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 34. France Drug Discovery Market by Service, 2019-2030, $ mn
Table 35. France Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 36. Spain Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 37. Spain Drug Discovery Market by Service, 2019-2030, $ mn
Table 38. Spain Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 39. Italy Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 40. Italy Drug Discovery Market by Service, 2019-2030, $ mn
Table 41. Italy Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 42. Russia Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 43. Russia Drug Discovery Market by Service, 2019-2030, $ mn
Table 44. Russia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 45. Drug Discovery Market in Rest of Europe by Country, 2019-2030, $ mn
Table 46. APAC Drug Discovery Market by Country, 2019-2030, $ mn
Table 47. Japan Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 48. Japan Drug Discovery Market by Service, 2019-2030, $ mn
Table 49. Japan Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 50. China Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 51. China Drug Discovery Market by Service, 2019-2030, $ mn
Table 52. China Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 53. Australia Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 54. Australia Drug Discovery Market by Service, 2019-2030, $ mn
Table 55. Australia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 56. India Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 57. India Drug Discovery Market by Service, 2019-2030, $ mn
Table 58. India Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 59. South Korea Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 60. South Korea Drug Discovery Market by Service, 2019-2030, $ mn
Table 61. South Korea Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 62. Drug Discovery Market in Rest of APAC by Country/Region, 2019-2030, $ mn
Table 63. South America Drug Discovery Market by Country, 2019-2030, $ mn
Table 64. Argentina Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 65. Argentina Drug Discovery Market by Service, 2019-2030, $ mn
Table 66. Argentina Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 67. Brazil Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 68. Brazil Drug Discovery Market by Service, 2019-2030, $ mn
Table 69. Brazil Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 70. Chile Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 71. Chile Drug Discovery Market by Service, 2019-2030, $ mn
Table 72. Chile Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 73. MEA Drug Discovery Market by Country, 2019-2030, $ mn
Table 74. UAE Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 75. UAE Drug Discovery Market by Service, 2019-2030, $ mn
Table 76. UAE Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 77. Saudi Arabia Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 78. Saudi Arabia Drug Discovery Market by Service, 2019-2030, $ mn
Table 79. Saudi Arabia Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 80. South Africa Drug Discovery Market by Drug Type, 2019-2030, $ mn
Table 81. South Africa Drug Discovery Market by Service, 2019-2030, $ mn
Table 82. South Africa Drug Discovery Market by Therapeutic Area, 2019-2030, $ mn
Table 83. Abbott Laboratories Inc.: Company Snapshot
Table 84. Abbott Laboratories Inc.: Business Segmentation
Table 85. Abbott Laboratories Inc.: Product Portfolio
Table 86. Abbott Laboratories Inc.: Revenue, 2018-2020, $ mn

List Of Figures

LIST OF FIGURES:

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2019-2030
Figure 4. Global Drug Discovery Market, 2019-2030, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Global Drug Discovery Market
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060
Figure 9. Primary Restraints and Impact Factors of Global Drug Discovery Market
Figure 10. Investment Opportunity Analysis
Figure 11. Porter’s Fiver Forces Analysis of Global Drug Discovery Market
Figure 12. Breakdown of Global Drug Discovery Market by Drug Type, 2019-2030, % of Revenue
Figure 13. Global Addressable Market Cap in 2021-2030 by Drug Type, Value ($ mn) and Share (%)
Figure 14. Global Drug Discovery Market by Drug Type: Small Molecule Drugs, 2019-2030, $ mn
Figure 15. Global Drug Discovery Market by Drug Type: Biologic Drugs, 2019-2030, $ mn
Figure 16. Breakdown of Global Drug Discovery Market by Service, 2019-2030, % of Sales Revenue
Figure 17. Global Addressable Market Cap in 2021-2030 by Service, Value ($ mn) and Share (%)
Figure 18. Global Drug Discovery Market by Service: Medicinal Chemical Services, 2019-2030, $ mn
Figure 19. Global Drug Discovery Market by Service: Biological Services, 2019-2030, $ mn
Figure 20. Global Drug Discovery Market by Service: Drug Metabolism and Pharmacokinetics (DMPK) Services, 2019-2030, $ mn
Figure 21. Global Drug Discovery Market by Service: Other Pharmaceutical Services, 2019-2030, $ mn
Figure 22. Breakdown of Global Drug Discovery Market by Process, 2019-2030, % of Sales Revenue
Figure 23. Global Addressable Market Cap in 2021-2030 by Process, Value ($ mn) and Share (%)
Figure 24. Global Drug Discovery Market by Process: Target Selection, 2019-2030, $ mn
Figure 25. Global Drug Discovery Market by Process: Target Validation, 2019-2030, $ mn
Figure 26. Global Drug Discovery Market by Process: Hit-To-Lead Identification, 2019-2030, $ mn
Figure 27. Global Drug Discovery Market by Process: Lead Optimization, 2019-2030, $ mn
Figure 28. Global Drug Discovery Market by Process: Candidate Validation, 2019-2030, $ mn
Figure 29. Breakdown of Global Drug Discovery Market by Technology, 2019-2030, % of Revenue
Figure 30. Global Addressable Market Cap in 2021-2030 by Technology, Value ($ mn) and Share (%)
Figure 31. Global Drug Discovery Market by Technology: High Throughput Screening, 2019-2030, $ mn
Figure 32. Global Drug Discovery Market by Technology: Combinatorial Chemistry, 2019-2030, $ mn
Figure 33. Global Drug Discovery Market by Technology: Pharmacogenomics and Pharmacogenetics, 2019-2030, $ mn
Figure 34. Global Drug Discovery Market by Technology: Nanotechnology, 2019-2030, $ mn
Figure 35. Global Drug Discovery Market by Technology: Bioanalytical Instruments, 2019-2030, $ mn
Figure 36. Global Drug Discovery Market by Technology: Biochips, 2019-2030, $ mn
Figure 37. Global Drug Discovery Market by Technology: Bioinformatics, 2019-2030, $ mn
Figure 38. Global Drug Discovery Market by Technology: Other Technologies, 2019-2030, $ mn
Figure 39. Breakdown of Global Drug Discovery Market by Therapeutic Area, 2019-2030, % of Revenue
Figure 40. Global Addressable Market Cap in 2021-2030 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 41. Global Drug Discovery Market by Therapeutic Area: Oncology, 2019-2030, $ mn
Figure 42. Global Drug Discovery Market by Therapeutic Area: Neurology, 2019-2030, $ mn
Figure 43. Global Drug Discovery Market by Therapeutic Area: Infectious and Immune System Diseases, 2019-2030, $ mn
Figure 44. Global Drug Discovery Market by Therapeutic Area: Digestive System Diseases, 2019-2030, $ mn
Figure 45. Global Drug Discovery Market by Therapeutic Area: Cardiovascular Diseases, 2019-2030, $ mn
Figure 46. Global Drug Discovery Market by Therapeutic Area: Diabetes, 2019-2030, $ mn
Figure 47. Global Drug Discovery Market by Therapeutic Area: Respiratory Disease, 2019-2030, $ mn
Figure 48. Global Drug Discovery Market by Therapeutic Area: Other Therapeutic Areas, 2019-2030, $ mn
Figure 49. Breakdown of Global Drug Discovery Market by End User, 2019-2030, % of Revenue
Figure 50. Global Addressable Market Cap in 2021-2030 by End User, Value ($ mn) and Share (%)
Figure 51. Global Drug Discovery Market by End User: Pharmaceutical Companies, 2019-2030, $ mn
Figure 52. Global Drug Discovery Market by End User: Contract Research Organizations (CROs), 2019-2030, $ mn
Figure 53. Global Drug Discovery Market by End User: Research Institutes, 2019-2030, $ mn
Figure 54. Global Drug Discovery Market by End User: Other End Users, 2019-2030, $ mn
Figure 55. Global Market Snapshot by Region
Figure 56. Geographic Spread of Worldwide Drug Discovery Market, 2019-2030, % of Sales Revenue
Figure 57. Global Addressable Market Cap in 2021-2030 by Region, Value ($ mn) and Share (%)
Figure 58. Health Spending as a Share of GDP by Country, 2015 and 2030
Figure 59. North American Drug Discovery Market, 2019-2030, $ mn
Figure 60. Breakdown of North America Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 61. Contribution to North America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 62. U.S. Drug Discovery Market, 2019-2030, $ mn
Figure 63. Canada Drug Discovery Market, 2019-2030, $ mn
Figure 64. Drug Discovery Market in Mexico, 2019-2030, $ mn
Figure 65. European Drug Discovery Market, 2019-2030, $ mn
Figure 66. Breakdown of European Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 67. Contribution to Europe 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 68. Drug Discovery Market in Germany, 2019-2030, $ mn
Figure 69. Drug Discovery Market in U.K., 2019-2030, $ mn
Figure 70. Drug Discovery Market in France, 2019-2030, $ mn
Figure 71. Drug Discovery Market in Spain, 2019-2030, $ mn
Figure 72. Drug Discovery Market in Italy, 2019-2030, $ mn
Figure 73. Drug Discovery Market in Russia, 2019-2030, $ mn
Figure 74. Drug Discovery Market in Rest of Europe, 2019-2030, $ mn
Figure 75. Asia-Pacific Drug Discovery Market, 2019-2030, $ mn
Figure 76. Breakdown of APAC Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 77. Contribution to APAC 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 78. Drug Discovery Market in Japan, 2019-2030, $ mn
Figure 79. Drug Discovery Market in China, 2019-2030, $ mn
Figure 80. Drug Discovery Market in Australia, 2019-2030, $ mn
Figure 81. Drug Discovery Market in India, 2019-2030, $ mn
Figure 82. Drug Discovery Market in South Korea, 2019-2030, $ mn
Figure 83. Drug Discovery Market in Rest of APAC, 2019-2030, $ mn
Figure 84. South America Drug Discovery Market, 2019-2030, $ mn
Figure 85. Breakdown of South America Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 86. Contribution to South America 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 87. Drug Discovery Market in Argentina, 2019-2030, $ mn
Figure 88. Drug Discovery Market in Brazil, 2019-2030, $ mn
Figure 89. Drug Discovery Market in Chile, 2019-2030, $ mn
Figure 90. Drug Discovery Market in Rest of South America, 2019-2030, $ mn
Figure 91. Drug Discovery Market in Middle East and Africa (MEA), 2019-2030, $ mn
Figure 92. Breakdown of MEA Drug Discovery Market by Country, 2019 and 2030, % of Revenue
Figure 93. Contribution to MEA 2021-2030 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 94. Drug Discovery Market in UAE, 2019-2030, $ mn
Figure 95. Drug Discovery Market in Saudi Arabia, 2019-2030, $ mn
Figure 96. Drug Discovery Market in South Africa, 2019-2030, $ mn
Figure 97. Growth Stage of Global Drug Discovery Industry over the Forecast Period